Affiliated Treatment Facilities
01. Doctor Overview
Doctor Overview
有近三十年的我dical experience, Dr. John A. Chabot is an expert in thesurgical treatmentof pancreatic cancer andperitoneal mesothelioma。Upon completion of his residency in 1991, Dr. Chabot signed on as surgical chief of the thyroid clinic at纽约长主教and assistant professor of surgery at Columbia University. He has remained at the hospital, in increasingly senior positions, ever since. Throughout the years, Dr. Chabot has remained satisfied and challenged at NewYork-Presbyterian because of the hospital’s depth of expertise and its culture of innovation. Dr. Chabot has researched and published numerous articles and abstracts on the surgical treatment of pancreatic, parathyroid, thyroid and liver disease, as well as peritoneal mesothelioma.
02. Fast Facts
Doctor Fast Facts
主要专业：一般手术
其他兴趣和专业：Cancer care, pancreatic disease, cysts, surgery, tumor and cancer, 万博专业版mesothelioma, thyroid cancer, liver cancer, hepatobiliary pancreas disease, pancreas and biliary tract surgery, gastrointestinal cancer, liver resection surgery, sarcoma, pancreatitis laparoscopic cholecystectomy and jaundice.
Certifications, Awards & Accolades:美国外科手术委员会手术委员会，被评为纽约杂志的顶级医生之一，杰里·格里克利希（Jerry Gliklich）年度最佳从业者奖，卓越的教学和指导手术教学奖
教育与经验：
- 达特茅斯医学院的医学学位
- 在哥伦比亚长老会医疗中心实习
- Residency at Columbia Presbyterian Medical Center
- 达特茅斯 - 希区柯克医学中心的奖学金
03. Publications
Publications
Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma。Histopathology。April 2016; 68(5): 729-737. doi:10.1111/his.12807
恶性腹膜间皮瘤患者的定量X射线计算机断层扫描截面截面学万博专业版。外科肿瘤学的年鉴。2013年12月：20（3）：553-559。doi：10.1245/s10434-013-2976-8
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials。European Journal of Surgical Oncology。October 2010; 36 (10): 997-1003. doi:10.1016/j.ejso.2010.07.001
Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal Mesothelioma。美国临床肿瘤学杂志。2008年2月；31（1）：49-54。doi：10.1097/coc.0b013e3180684181
P16丧失和有丝分裂活性预测腹膜恶性间皮瘤患者的存活率不佳万博专业版。临床癌症研究。May 2005; 11(9): 3303-3308. doi:10.1158/1078-0432.CCR-04-1884
通过腹膜内化学疗法治疗原发性腹膜间皮瘤万博专业版。Perfusion。March 1999;14(2):141-5. doi:10.1177/026765919901400208
